05/20/2019 | Press release | Distributed by Public on 05/20/2019 13:12
CINCINNATI--(BUSINESS WIRE)--May 20, 2019-- Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2019 annual shareholders' meeting. Each of the directors continues from the prior term.
Shareholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2019 and approved Chemed's executive compensation. In addition, shareholders voted in favor of management's recommendation to reject the shareholder proposal requesting a semi-annual report on the Company's policies on political spending and political contributions made.
Following the shareholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 30 cents per share on the Company's capital stock, payable on June 19, 2019, to shareholders of record as of May 30, 2019. This represents the 192nd consecutive quarterly dividend paid to shareholders in Chemed's 48 years as a public company.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care, and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance.Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements.Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190520005698/en/
Source: Chemed Corporation
David P. Williams